Ultrasound appears to be a better option than either CT or fluoroscopy for guiding percutaneous biopsies of the soft-tissue component of osteosarcoma. That's the conclusion of researchers from M.D. Anderson Cancer Center in Houston, who presented their findings at the 2004 Society of Interventional Radiology in Phoenix.
Dear Ultrasound Insider,
Ultrasound appears to be a better option than either CT or fluoroscopy for guiding percutaneous biopsies of the soft-tissue component of osteosarcoma. That's the conclusion of researchers from M.D. Anderson Cancer Center in Houston, who presented their findings at the 2004 Society of Interventional Radiology in Phoenix.
The group found during a three-year review that ultrasound biopsies were 100% accurate, while CT or fluoroscopic biopsies produced an accuracy rate of 83%. As an Ultrasound Radiology Insider subscriber, you have access to this story before it is published for the rest of our AuntMinnie.com members. You’ll find our featured article here.
In other developments, breast ultrasound research is heating up. The American College of Radiology Imaging Network (ACRIN) recently announced it began enrolling patients in March for "Screening Breast Ultrasound for High-Risk Women," a trial that aims to include 3,000 women at 20 institutions. For more information on that study, go here.
Also, be sure to check in on the Ultrasound Digital Community mid-month. AuntMinnie.com will be attending the 24th Leading Edge in Diagnostic Ultrasound conference, to be held May 11-14 in Atlantic City. Stay tuned for on-site and follow-up reports.
Is there a topic you'd like to see covered, or an article you'd like to submit? As always, please feel free to drop me a line.
